Bevacizumab in Combination with FOLFIRI in the First-Line Treatment of Patients with Advanced Colorectal Cancer: A Single-Institution Experience. J. Anal. Oncol. 2014;3(1): 26-32. doi:10.6000/1927-7229.2014.03.01.4